For years, Founder Shield was one of the names you heard whenever someone talked about digital-first brokers for startups. It built a tech-driven platform for emerging and high-growth companies across life sciences, tech and media, fintech and small business, and served more than 20,000 clients. The Baldwin Group bought it in 2021 and let it keep its own brand. On Oct. 13, 2026, that ended: Founder Shield completed its rebrand to The Baldwin Group and became the firm's Innovation Practice.
That's a bigger signal than a logo change. One of the best-known insurtech brokers in the startup market is now fully inside a national broker's brand. I sent written questions to Kyle Jeziorski, Managing Director of the Innovation Practice at The Baldwin Group, about why now, what happens to the platform, and what the move says about the standalone insurtech broker model. He also shared what 20,000 clients have taught the team about how coverage needs change from seed to IPO, which is worth the read on its own if you sell to emerging companies.
Founder Shield joined Baldwin in 2021 and kept its own brand for five years. Why retire the name now, and what changed?
Kyle Jeziorski: Since joining The Baldwin Group in 2021, we've continued to grow, expand our capabilities, and become more integrated with the broader organization.
Five years later, we're in a different place than when we first joined, and the rebrand from Founder Shield to the Innovation Practice of The Baldwin Group reflects that growth.
We've reached a point where operating under one name better reflects how we operate today while maintaining the expertise and relationships our clients trust. The Baldwin Group's clients can expect the same tech-powered user experience, accompanied by more market access and a deeper bench of experts to consult.
Founder Shield built its reputation with startups and VC-backed companies that liked buying from a digital-first broker. How do you keep those clients from feeling like they've been absorbed by a big firm?
Kyle Jeziorski: Our clients expect a digital-first experience when working with us, and we strive to deliver that type of seamless experience for them. The Baldwin Group has been in our corner since becoming our parent company in 2021, and in that time, we've purposefully kept and improved our technology.
We remain dedicated to our tech-enabled approach, from client-facing touchpoints to back-end execution. With our technology and support from The Baldwin Group, we look forward to expanding our reach, elevating our offerings, and setting new benchmarks for our industry in the years ahead.
What does "Innovation Practice" actually mean inside Baldwin day to day? Is it a client segment, a technology team, a product lab, or all three?
Kyle Jeziorski: The Innovation Practice is a boutique team within The Baldwin Group, specifically built to serve emerging sectors, high-growth startups, and tech-enabled companies.
Is the digital platform being rolled out to other Baldwin producers and clients, or does it stay focused on high-growth companies?
Kyle Jeziorski: Our digital platform remains focused on high-growth companies for now. However, colleagues across the broader firm often recognize a "good fit" and refer clients to the Innovation Practice regularly, widening the impact of our technology.
What does this move say about the standalone insurtech broker model? Is independence still viable at scale, or does every digital broker eventually end up inside a larger one?
Kyle Jeziorski: Goals drive intentional change, and our integration into The Baldwin Group was purposeful. Our goals included:
While standalone insurtech broker models can achieve success, scaling and growing effectively, our specific goals required us to shift our structure. We went from being a tech-first niche broker to a digitally enabled broker backed by nationwide scale and capital.
Life sciences, tech and media, and fintech all have very different risk profiles. Which of those segments is changing fastest right now, and how is that showing up in coverage needs?
Kyle Jeziorski: In short, each of these industries is changing rapidly, with most of the changes centering on artificial intelligence (AI). As a result, the insurance market is still working through how best to address AI. Many underwriters are taking a measured approach, with limited AI-specific language in some policies and exclusions in others, which leaves these industries looking for dedicated risk management solutions.
In life sciences, AI is speeding up drug discovery and medical tech, shifting risk away from traditional lab tests and toward algorithm accuracy, patient data privacy, and software reliability.
In the financial sector, AI is complicating fraud and security. For example, deepfakes make it easy to spoof wire transfers, while automated tools create new regulatory headaches for credit and decision-making.
Tech and media face challenges as AI upends copyright and content creation, which is steering companies to look for coverage that protects against IP disputes, deepfakes, and generated-content risks.
Emerging companies tend to underbuy D&O, cyber, and E&O early on. What's the most common coverage mistake you see founders make, and when does it usually come back to bite them?
Kyle Jeziorski: The most common mistake we see founders make is waiting until a contractual requirement forces them to buy insurance.
Two major components of insurance pricing are company revenue and loss history. When you first launch, revenues are low, and premiums reflect that. This lets you build loss history and credibility at a low cost.
If you wait to purchase insurance until you have a major contract that requires it, you will not have loss history or credibility in the market, which can lead to more underwriting scrutiny and higher premiums.
With 20,000+ clients served, what has the data taught you about how a company's insurance needs shift from seed to Series B to IPO?
Kyle Jeziorski: Across our client relationships, the data shows that risk doesn't scale in a straight line. Instead, we notice inflection points as focus shifts from scaling to institutional governance. Insurance is mostly transactional in the early stages, a task for founders to check off their to-do list and driven mostly by compliance requirements. As mentioned earlier, we often see founders prompted to purchase D&O or other coverage due to a contractual requirement in the Seed or even Series A stage.
By Series B fundraising, liabilities shift toward governance and operational scale, making D&O and EPL insurance mandatory conditions to close rounds. And the stakes increase from there, through higher fundraising rounds and finally to an IPO. It's at this point that insurance transforms into a strategic financial tool. We see public D&O, tail coverage, and reps and warranties become essential to protect leaders and the company.
Kyle is candid about the trade: Founder Shield gave up its name to get carrier leverage, a deeper bench and enterprise backing. Whether every digital broker ends up inside a bigger one is still an open question, but this is one more data point that scale tends to win. For producers working the startup market, the practical gem is the founder mistake: buying only when a contract forces it means walking into underwriting with no loss history at exactly the moment the stakes go up. Get them insured early, while premiums are small and the track record is cheap to build.
Thanks to Kyle Jeziorski, Managing Director, Innovation Practice at The Baldwin Group, for taking the time. Learn more about The Baldwin Group and the former Founder Shield.